Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ovarian Neoplasms

Free Subscription 04.08.2025 1 Am J Obstet Gynecol 1 Anticancer Drugs 1 Clin Cancer Res 1 Curr Opin Obstet Gynecol 5 Eur J Obstet Gynecol Reprod Biol 1 Gynecol Oncol 1 Int J Gynaecol Obstet 1 J Natl Cancer Inst

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. KARSTENSEN S, Jochumsen K, Hogdall C, Hogdall E, et al
   Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers.
   Am J Obstet Gynecol. 2025 Jan 21:S0002-9378(25)00029.
   PubMed         Abstract available
   
   

   
   Anticancer Drugs

2. WANG Y, Xu Z, He C, Qu H, et al
   E26 transformation-specific transcription factor 3 tips the balance: repressing tropomyosin 2 to fuel Yes-associated protein 1-driven cisplatin resistance in ovarian cancer.
   Anticancer Drugs. 2025 Aug 1. doi: 10.1097/CAD.0000000000001761.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

3. KNISELY A, Dai Y, Barlow GL, Lee S, et al
   Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunities.
   Clin Cancer Res. 2025 Aug 1. doi: 10.1158/1078-0432.CCR-25-0512.
   PubMed         Abstract available
   
   

   
   Curr Opin Obstet Gynecol

4. MCLOUGHLIN K, Merritt MA
   Opportunistic salpingectomy for prevention of ovarian cancer among the general population.
   Curr Opin Obstet Gynecol. 2025 Jul 22. doi: 10.1097/GCO.0000000000001051.
   PubMed         Abstract available
   
   

   
   Eur J Obstet Gynecol Reprod Biol

5. BILLMIRE DF, Turk F, Harris AK, Muraru R, et al
   Surgical staging for ovarian sex cord-stromal tumors: What procedural steps are needed?
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114522.
   PubMed         Abstract available
   
   
6. RAY MD, Kapoor R
   Paraneoplastic syndromes in ovarian carcinoma: A study on clinical spectrum, treatment and survival perspectives.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114114.
   PubMed         Abstract available
   
   
7. RAY MD, Kapoor R, Banthia P
   The nodal cancer index (NCI): An objective approach for systematic lymph node dissection in ovarian carcinomatosis.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114113.
   PubMed         Abstract available
   
   
8. LI J, Lu L, Duan J, Gu P, et al
   Fertility-sparing strategies in borderline and malignant ovarian tumors: a comparative analysis of international guideline recommendations.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114111.
   PubMed         Abstract available
   
   
9. YOONG W, Penny Z, Ho J, Ariyo O, et al
   Outcomes and cost-effectiveness of vNOTES vs conventional laparoscopic ovarian cystectomy for ovarian teratoma (dermoid cysts): A comparison of two minimal access routes of surgery.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114087.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

10. WANG JY, Simons EJ, Dingel A, Pike MM, et al
    Impact of chemotherapy provider specialty on outcomes in ovarian cancer.
    Gynecol Oncol. 2025;200:122-129.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

11. VO HL, Tran DT, Le LH, Nguyen TTN, et al
    Comparative diagnostic performance of the early-stage ovarian malignancy score versus other risk prediction models in early-stage ovarian cancer: A Vietnamese prospective cohort study.
    Int J Gynaecol Obstet. 2025 Jul 31. doi: 10.1002/ijgo.70383.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

12. JONES RR, Madrigal JM, Medgyesi DN, Fisher JA, et al
    Serum concentrations of per- and polyfluoroalkyl substances and risk of ovarian cancer.
    J Natl Cancer Inst. 2025 Aug 1:djaf204. doi: 10.1093.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.